Open an IV Therapy & Infusion Clinic.
One of the Lowest Barriers to Entry in the Space.
Drip bars, immune support, and athletic recovery infusions, with NAD+ as the premium upsell tier. The IV therapy category is one of the fastest-growing wellness verticals and one of the most accessible to launch, provided you build the menu on protocols that hold up to scrutiny.
Book a Strategy CallA $8B Market Growing
at Double-Digit Rates
The IV therapy and infusion wellness market has expanded from a niche recovery treatment to a mainstream consumer health category. Athletes, executives, and health-conscious consumers across every demographic are actively seeking IV wellness services, and in most mid-size markets, supply is still catching up to demand.
The entry barriers are lower here than almost any other regenerative health category. The equipment investment is modest, the service menu is straightforward, and consumer understanding of IV therapy is already high, meaning less patient education and faster conversion from first inquiry to first appointment.
IV therapy works as a powerful standalone model and as an immediate revenue add-on for any longevity, hormone, or aesthetics clinic. It's often the fastest path to early cash flow in a new clinic launch.
What an IV Therapy & Infusion Clinic Actually Offers
The service menu ranges from foundational wellness drips to advanced clinical infusion protocols, allowing the clinic to serve casual wellness consumers and performance-focused patients from the same chair.
Myers' Cocktail, high-dose Vitamin C, B-complex, and magnesium infusions. The entry point for most new IV patients, high volume, fast turnaround, strong reorder rate.
Nicotinamide Adenine Dinucleotide as a premium upsell within the broader IV menu. One of the highest-ticket infusion protocols with a loyal, high-retention patient base, and it complements foundational wellness drips rather than replacing them.
High-dose Vitamin C, zinc, and glutathione. Seasonal demand spikes create predictable high-volume windows. Strong walk-in and membership conversion.
Hydration, amino acid, and electrolyte infusions for post-event or post-workout recovery. Natural partnership with gyms, sports facilities, and performance clinics.
MIC injections, lipotropic blends, and metabolic support infusions. Natural revenue add-on for clinics in the weight loss space, see our Metabolic Weight Loss page for the full GLP-1 model.
Licensed nurses delivering infusions to homes, offices, and hotels. Premium pricing for convenience, lower fixed overhead, and a genuine differentiator in competitive markets. State rules on mobile administration vary.
Why ACG Does Not Build on EBOO or Ozone.
EBOO, extracorporeal blood oxygenation and ozonation, is one of the most searched terms in this category. Operators ask us about it constantly, usually because a competitor advertises it or an equipment vendor pitched it as a premium differentiator.
We steer clients away from it, and we would rather explain why than quietly leave it off the menu.
The FDA classifies ozone under 21 CFR 801.415 as a toxic gas with no known useful medical application. No ozone therapy device is FDA-approved in the United States. In July 2025 the agency issued a warning letter over the distribution of unapproved autohemotherapy and EBOO devices. EBOO is not FDA-approved for any condition and remains experimental.
A premium tier that rests on an unapproved device is not a differentiator. It is a liability with a price list attached.
The commercial goal behind an EBOO offering is almost always the same: a high-ticket, low-volume protocol that lifts average revenue per visit and positions the clinic above the drip-bar tier.
NAD+ already does that job, with a loyal patient base and no unapproved device in the room. High-dose Vitamin C, glutathione, and structured membership programs fill out the premium end.
If you decide to offer ozone anyway, that is your call as the owner and your Medical Director's call clinically. Understand that state positions vary, several restrict it outright, equipment certification is unsettled, and neither ACG nor your marketing can make claims about what it treats.
Current as of September 2026. Regulatory positions change. Verify with your Medical Director, your state board, and qualified counsel before any clinical or equipment decision. ACG is a business consulting firm and this is not legal, medical, or regulatory advice.
Accessible to Launch,
With the Right Structure
IV therapy is one of the more accessible categories in terms of launch complexity, but it still requires a properly structured Medical Director relationship, state-specific scope of practice compliance, and a defensible protocol framework before the first patient is seen.
Sterile preparation is where most IV clinics get caught. Compounding standards, beyond-use dating, and documentation are the details that turn a routine inspection into a problem. ACG builds that framework before you open rather than after a finding.
The compliance structure for an IV clinic can be set up correctly from day one, or corrected after the fact at significant cost. ACG builds it right the first time.
All IV infusion services require physician oversight. ACG introduces clients to vetted Medical Directors with IV therapy experience, matched to your state and service menu.
Who can start IVs, what supervision is required, and how the Medical Director oversight model is structured varies significantly by state. ACG maps this for your location.
Every proposed protocol is checked against its regulatory footing before it reaches a price list. Unapproved devices and unapproved uses do not make it onto an ACG-built menu.
ACG connects clients to pre-vetted compounding pharmacy partners for custom IV formulations, with preferred pricing negotiated across the ACG portfolio.
Informed consent, standing orders, emergency protocols, and treatment documentation, all structured to protect the clinic and meet state board requirements.
Why IV Therapy Builds
Recurring Revenue Fast
IV therapy patients return frequently, weekly hydration patients, monthly NAD+ protocols, seasonal immune support. The membership model works particularly well in this category, converting one-time visitors into predictable monthly revenue.
The clinic also benefits from a walk-in model that most other regenerative categories cannot support. No consultation required, no long intake process, a patient can walk in and be treated in under an hour. That operational simplicity drives volume.
$150-$600+
Per session. NAD+ commands the premium end. Volume compounds as word of mouth grows.
High Retention
Monthly membership packages convert single-visit patients into predictable recurring revenue.
Lower Than Most
Modest equipment investment, chair-based model, and an accessible patient acquisition channel.
Launch Window
From keys received, market and regulatory conditions permitting.
Answers Before
You Open.
Operators looking at IV therapy want straight answers on prescriber and RN structure, sterile preparation, equipment economics, and which premium protocols are worth building on. Honest answers below, including the uncomfortable one.
If something isn't covered here, that's what the consultation is for. No pressure, no pitch.
View All FAQsShould my clinic offer EBOO or ozone therapy?
What services does a typical IV therapy and infusion clinic offer?
Are IV therapy clinics legally compliant on a cash-pay basis?
Do I need to be a physician to open an IV therapy clinic?
What's the equipment investment for an IV therapy clinic?
How are IV therapy clinics typically marketed?
How are infusion services typically priced?
Can an IV therapy clinic operate as a mobile or concierge service?
One of the Fastest Categories
to Launch and Monetize.
Book a free 30-minute strategy call. ACG will walk you through the IV therapy opportunity in your specific market, the demand data, the compliance structure, and what the launch process looks like from first conversation to open doors.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time
Structured to keep you on the right side of the line.
Regenerative health is one of the most heavily scrutinized spaces in medicine. Knowing the rules is not a footnote to what we do. It is the foundation. Here is how we structure every clinic we help launch.
Your Medical Director Directs Care
You own and operate the business. Every clinical, prescribing, and treatment decision is made by an independent, state-licensed Medical Director, structured to respect Corporate Practice of Medicine laws in your state. We connect you to a vetted network; you retain your own provider.
We Know the Regulatory Lines
PRP, peptides, GLP-1 medications, and cellular products each carry their own federal and state rules, and not every product or use is FDA-approved. Some, like exosomes for therapeutic use, are not FDA-approved at all, and we steer you away from them. We help you build a treatment menu on defensible, compliant options and a marketing approach that holds up to FDA, FTC, and state medical board scrutiny.
No Hype. No Guarantees.
We show you real ranges, not fantasy numbers, and we never promise an income or a clinical outcome. What you earn depends on your market, your capital, and your execution. We would rather set honest expectations than sell you a dream.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe, or sell any drug, biologic, device, or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the regulatory compliance of every product, therapy, and claim. See our full regulatory notice below.